免费v pn2025

免费v pn2025

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

免费v pn2025

Learn More
Folded page of a newspaper

免费v pn2025

免费v pn2025

Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results

免费v pn2025

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

免费v pn2025

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

免费v pn2025

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

免费v pn2025

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

免费v pn2025

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

跨国免费加速器  加速服务器安卓  回锅肉vp n加速器  v2免费节点网站  快连letsgopro官网  猎豹加速下载安装官网  极光加速器64Mb  蚂蚁ant加速器无限流量